U.S. Senator Mark Kelly and actress Olivia Munn are drawing renewed attention to breast cancer risk assessment, as they promote the proposed Know Your Risk Act, legislation designed to help more women understand their personal risk and receive appropriate screening. A Capitol Hill press conference featuring Kelly, Munn and other advocates was listed for Wednesday, November 18, by the U.S. Senate Radio-TV Correspondents Gallery. The initiative grew out of Munn’s experience with breast cancer and her belief that a risk assessment helped lead to further testing. Event details | Kelly’s office

Actress Olivia Munn during an interview about her breast cancer diagnosis and advocacy for risk assessment
Olivia Munn has used her breast cancer experience to advocate for wider access to risk assessments. Image: Entertainment Tonight.

How Munn’s Diagnosis Inspired The Campaign

Munn has explained that her diagnosis in 2023 came after a series of initial tests, including a mammogram and genetic testing, had not raised concerns. Her doctor then calculated her lifetime breast cancer risk using the Tyrer-Cuzick assessment model. Munn’s score was 37.3 per cent, a result that prompted additional imaging; an MRI detected tumours in both breasts. She later underwent a double mastectomy as part of her treatment. PEOPLE’s interview with Munn | CBS News background

The experience changed the direction of Munn’s public advocacy. She has said she wants women to know that risk assessment tools exist and that healthcare professionals should discuss personal risk as routinely as they ask about blood pressure, cholesterol, height and weight. Her mother later received an elevated risk score and was diagnosed with early-stage breast cancer after further investigation, reinforcing Munn’s determination to make these assessments more widely understood. PEOPLE | ABC News

What The Know Your Risk Act Seeks To Change

As described by Kelly and Munn in their earlier public comments, the proposed federal effort is intended to make breast cancer risk assessment a more consistent part of routine preventive care. The plan has included establishing a task force to recommend ways to improve access to assessment tools and directing federal health agencies, including the Department of Health and Human Services and the National Institutes of Health, to examine the tools’ accuracy and performance. The broader goal is to help clinicians identify patients who may benefit from more intensive screening or other follow-up. Senator Kelly’s statement | The View interview

Kelly has a personal connection to the issue: he has said that both his mother and grandmother had breast cancer. He credited Munn with putting significant effort into developing the proposal and said he wanted to turn the lessons from her experience into practical policy. The two have framed the legislation as an effort to close the gap between medical information that is already available and the information patients actually receive during routine appointments. Kelly’s office | PEOPLE

Risk Assessments Are Not Cancer Diagnoses

Breast cancer risk calculators estimate the likelihood of developing the disease over a specified period; they do not determine whether a person currently has cancer or predict an individual’s future with certainty. Different models use different combinations of information, such as age, family history, reproductive and medical history, and other risk factors. The National Cancer Institute advises people to discuss their results with a healthcare professional, who can explain what the estimate means and whether additional screening is appropriate. National Cancer Institute: Understanding Breast Cancer Risk Tools

The distinction matters because a low risk estimate does not eliminate the possibility of cancer, while a high score does not mean a person will inevitably develop the disease. The American Cancer Society recommends that women at certain elevated-risk levels discuss annual MRI screening alongside mammography with their healthcare providers. Screening decisions should be based on individual circumstances and professional medical advice. American Cancer Society: Screening For Women At High Risk | National Cancer Institute

A Separate House Proposal Shares The Same Name

There is also a separate House measure carrying the same title. Representative Julia Letlow introduced H.R. 10763, the Know Your Risk Act, on October 6, 2026, and it was referred to the House Committee on Energy and Commerce. Its published text directs the Department of Health and Human Services to report to Congress on breast cancer risk assessment tools. This House bill should not be confused with Kelly’s separately discussed Senate proposal; the available reporting ahead of the November 18 event described Kelly’s plan as upcoming Senate legislation. Official H.R. 10763 text at GovInfo | Kelly’s October 29 statement

Why The Proposal Matters

The campaign places an important question before the healthcare system: how can patients benefit from risk information if they do not know that the assessments exist or are never offered them during routine care? By encouraging clinicians to assess risk and explain the results, the proposal aims to make preventive care more proactive and help guide decisions about further screening. Its impact will depend on the final bill language, its passage through Congress, and how any new requirements are implemented. PEOPLE | National Cancer Institute

For Munn, the effort is a way to turn a deeply personal health experience into a wider public-health conversation. For Kelly, whose family has also been affected by breast cancer, it is an opportunity to pursue a policy response. Their message is that risk assessment should be easier to access, better understood and connected to informed conversations between patients and their doctors. Watch Kelly discuss the proposal on ABC’s The View | Senator Kelly’s office